Stay updated on Nivolumab vs Temozolomide in GBM Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Temozolomide in GBM Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-06T11:37:44.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Minor revision updates were applied: v3.4.2 added and v3.4.1 removed, with no user-facing content or functionality changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T14:59:48.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0 in the metadata. This is a minor versioning update and does not alter study content or functionality.
    Difference
    0.0%
    Check dated 2026-02-05T06:34:33.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now shows a glossary and QC-related metadata (Last Update Submitted that Met QC Criteria) along with No FEAR Act Data and Revision: v3.4.0. The older QC field capitalization (Last Update Submitted that met QC Criteria), the No FEAR Act data, and Revision: v3.3.4 were removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-29T03:11:45.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaced the prior v3.3.3 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:57:49.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a detailed Locations section listing participating sites across the United States, Canada, United Kingdom, Australia, and Japan. This helps potential participants identify nearby sites and understand where the study is being conducted.
    Difference
    2%
    Check dated 2025-12-23T09:54:10.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Temozolomide in GBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.